Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/pds.5412

PubMed Identifier: 35092316

Publication URI: http://europepmc.org/abstract/MED/35092316

Type: Journal Article/Review

Volume: 31

Parent Publication: Pharmacoepidemiology and drug safety

Issue: 4

ISSN: 1053-8569